ArticleFrontiers in immunology2025
The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target.
Yunpeng Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it